Literature DB >> 19464336

Role of MAPK/AP-1 signaling pathway in the protection of CEES-induced lung injury by antioxidant liposome.

Sutapa Mukhopadhyay1, Shyamali Mukherjee, William L Stone, Milton Smith, Salil K Das.   

Abstract

We have recently reported that antioxidant liposomes can be used as antidotes for mustard gas induced lung injury in guinea pigs. The maximum protection was achieved with a liposome composed of tocopherols (alpha, gamma, delta) and N-acetylcysteine (NAC) when administered after 5 min of exposure of 2-chloroethyl ethyl sulfide (CEES), a half sulfur mustard gas. We also reported an association of mustard gas-induced lung injury with an activation of MAPK/AP-1 signaling pathway and cell proliferation. The objective of the present study was to investigate whether CEES-induced MAPKs/AP-1 signaling pathway is influenced by antioxidant liposome therapy. A single dose (200 microl) of the antioxidant liposome was administered intratracheally after 5 min of exposure of CEES (0.5 mg/kg). The animals were sacrificed after 1h and 30 days of CEES exposure. Although the liposome treatment did not have any significant effect on the activation of the MAPKs family (ERK1/2, p38 and JNK1/2), it significantly counteracted the CEES-induced activation of AP-1 transcription factors and corresponding increase in the protein levels of Fos, ATF and Jun family members. The liposome treatment significantly blocked the CEES-induced increase in the protein levels of cyclin D1, a cell cycle protein and PCNA, a cell differentiation marker. Furthermore, it protected lung against CEES-induced inflammation and infiltration of neutrophils, eosinophils and erythrocytes in the alveolar space. This suggests that the protective effect of antioxidant liposome against CEES-induced lung damage is mediated via control of AP-1 signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464336     DOI: 10.1016/j.tox.2009.05.010

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  15 in total

Review 1.  Inflammatory mechanisms of pulmonary injury induced by mustards.

Authors:  Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Kinal N Vayas; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Lett       Date:  2015-10-23       Impact factor: 4.372

Review 2.  Nanocarriers for vascular delivery of antioxidants.

Authors:  Elizabeth Hood; Eric Simone; Paritosh Wattamwar; Thomas Dziubla; Vladimir Muzykantov
Journal:  Nanomedicine (Lond)       Date:  2011-09       Impact factor: 5.307

Review 3.  Sulfur mustard-induced pulmonary injury: therapeutic approaches to mitigating toxicity.

Authors:  Barry Weinberger; Jeffrey D Laskin; Vasanthi R Sunil; Patrick J Sinko; Diane E Heck; Debra L Laskin
Journal:  Pulm Pharmacol Ther       Date:  2010-09-17       Impact factor: 3.410

Review 4.  Anti-TNFα therapy in inflammatory lung diseases.

Authors:  Rama Malaviya; Jeffrey D Laskin; Debra L Laskin
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

Review 5.  Oxidants and antioxidants in sulfur mustard-induced injury.

Authors:  Jeffrey D Laskin; Adrienne T Black; Yi-Hua Jan; Patrick J Sinko; Ned D Heindel; Vasanthi Sunil; Diane E Heck; Debra L Laskin
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

6.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

7.  Attenuation of acute nitrogen mustard-induced lung injury, inflammation and fibrogenesis by a nitric oxide synthase inhibitor.

Authors:  Rama Malaviya; Alessandro Venosa; Leroy Hall; Andrew J Gow; Patrick J Sinko; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-06       Impact factor: 4.219

Review 8.  Emerging targets for treating sulfur mustard-induced injuries.

Authors:  Shama Ahmad; Aftab Ahmad
Journal:  Ann N Y Acad Sci       Date:  2016-06-10       Impact factor: 5.691

Review 9.  The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics.

Authors:  Prachi Gupta; Brendan L Thompson; Banrida Wahlang; Carolyn T Jordan; J Zach Hilt; Bernhard Hennig; Thomas Dziubla
Journal:  Drug Deliv Transl Res       Date:  2018-06       Impact factor: 4.617

Review 10.  Mustard vesicant-induced lung injury: Advances in therapy.

Authors:  Barry Weinberger; Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-19       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.